Open AccessIgE‐binding to vicilin‐like antimicrobial peptides is associated with systemic reactions to macadamia nut
Author(s) -
Ehlers Anna M.,
Rohwer Stefanie,
Otten Henny G.,
Brix Bettina,
Le ThuyMy,
Suer Waltraud,
Knulst André C.
Publication year - 2020
Publication title -
clinical and translational allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.979
H-Index - 37
ISSN - 2045-7022
DOI - 10.1186/s13601-020-00364-5
Subject(s) - macadamia nut , brazil nut , nut , vicilin , immunoglobulin e , medicine , proteaceae , food allergy , allergy , immunology , food science , horticulture , botany , biology , biochemistry , storage protein , antibody , engineering , structural engineering , gene
Abstract Background Macadamia nut can induce fatal allergic reactions and changes in dietary habits will raise their consumption in industrialised countries. Until now diagnosis of macadamia nut allergy by sIgE solely relies on the macadamia nut extract, but single components are lacking. Methods Macadamia nut proteins recognised by IgE from 2 macadamia nut extract positive sera were identified by mass spectrometry (vicilin‐like antimicrobial peptides: VLAP). Sensitisation to macadamia nut extract and heterologously expressed isoform VLAP‐2–3 was evaluated in 82 nut allergic (NA) and 27 tolerant (NT) patients (no tree nut allergy reported) comprehending 10 macadamia nut allergic (MA) and 18 explicitly reported macadamia nut tolerant patients (MT), using line blots. Co‐sensitisation to additional VLAP isoforms and other vicilins was evaluated in 8 MA, 12 MT and 14 NA patients sensitised to VLAP‐2–3. Functional properties were determined by indirect basophil activation. Results Even though proteins recognised by IgE were identified as VLAP‐2–1, 2–2 and 2–3, only peptides specifically belonging to VLAP‐2–3 were detected by mass spectrometry. The macadamia nut extract was recognised by 33% of NA patients (27/82) including 3 MA patients and 26% of NT patients (7/27, 3 MT). Similarly, 29% of NA (24/82) patients showed partly strong sIgE‐binding to VLAP‐2–3 including 3 MA patients with systemic reactions to macadamia nut. Contrary, VLAP‐2–3 was recognised by only 2 NT (1 MT) patients (7%) with very low sIgE titres. Simultaneous recognition of the isoforms VLAP‐2–1 and 2–2 was observed in all patients positive for VLAP‐2–3 with partly reduced sIgE titres in 59% of these patients. Additionally, all three VLAP isoforms were able to repeatedly induce BAT reactivity upon sensitisation with a MA serum. Conclusion VLAP proteins are the first described macadamia nut components with serological and functional allergenic properties and they are associated with systemic reactions to macadamia nut.